HIGHLIGHTS
- who: Luca Melazzini from the Department of Biomedical Sciences for Health, University of Milan, Milan, Italy, Laboratory of Muscle Histopathology and have published the research: Rare Disease: Cardiac Risk Assessment With MRI in Patients With Myotonic Dystrophy Type 1, in the Journal: (JOURNAL) of 09/01/2020
- what: In light of these considerations, the aim of the study was to evaluate ECV and strain on CMR in DM1 patient and appraise whether they could be viable imaging-biomarkers of subclinical cardiac pathology. The study has some limitations, the most important being its small sample size . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.